About: medicines Archives

  • OECD urges harmonisation of clinical trials to save lives

    News | Health 26-02-2013

    The OECD is urging its member governments to harmonise their clinical trial approval processes, citing a decline in the pharmaceutical sector in the EU, where the number of applications for clinical trials fell 25% between 2007 and 2011.

  • Parliament votes for quicker access to generic drugs

    News | Health 06-02-2013

    Voting on a draft law Wednesday (6 February), the European Parliament said patients should have quicker access to cheaper generic medicines. The draft rules will require national authorities to meet new deadlines and transparency standards on pricing and reimbursement.

  • Drugmakers suffer decline in trust, report says

    News | Public Affairs 14-01-2013

    The overall corporate reputation of pharmaceutical companies declined in 2012 compared to 2011, according to an independent study by patients' organisations.

  • Parliament backs transparency on medicine pricing

    News | Health 20-12-2012

    More transparency on the pricing and reimbursement of medicines should be the rule for the future to improve patient's access to affordable treatments, MEPs said after backing draft legislation in the environment and public health committee.

  • Antibiotics: Preserving a precious resource

    Opinion | Health 04-06-2012

    Antibiotics are a precious resource but they are often wasted on treating cold and flu's, with the dangerous effect that bacteria can develop resistance to them, writes Dr. Fidelma Fitzpatrick. However, there are many things policymakers and healthcare professional can do to preserve the efficacy of antibiotics, she says.

  • Standardisation and healthcare services do not mix

    Opinion | Health 22-03-2012

    Draft EU legislation seeks to bring services under the European standardisation system, with a view to improving their free movement in the single market. Yet in the case of healthcare, such standardisation threatens patient safety, says Dr Konstanty Radziwill.

  • ACTA and access to medicines: flawed process, rationale and agreement

    Opinion | Health 08-03-2012

    The Anti-Counterfeiting Trade Agreement (ACTA) has been characterised by a flawed process of negotiations based on a flawed rationale, which has resulted in a flawed agreement, argue Sophie Bloemen and Tessel Mellema from Health Action International Europe. One of the concerns now is that – designed to be a global norm-setting instrument - ACTA could deter generic competition of medicines around the world.

  • Tell people how to take pills, Commission urged

    News | Health 23-09-2011

    Health specialists urged  the European Commission to include provisions to its revised proposal for the controversial Information to Patients directive, expected for early October, so that patients are fully instructed on how to take medicine properly.

  • Lawmakers tighten rules on drug information to patients

    News | Health 25-11-2010

    Patients should get better information on prescription drugs following a vote in the European Parliament yesterday (24 November) that aims to better educate consumers and protect them from hidden advertising.

  • Medical innovation: Changing an ailing system

    News | Health 22-11-2010

    The system for medical innovation is broken. The number of people struggling to obtain or afford essential medicines is rising at a dangerous pace. There must be a radical overhaul, said experts at a European Parliament hearing on Thursday (18 November).

  • Medicines in emerging markets

    LinksDossier | Health 05-11-2010

    Fast-growing economies such as China and India could provide lucrative new markets for Europe's pharmaceutical industry, but emerging nations are investing heavily in their own medicines sector and look set to challenge Western dominance of the healthcare market.

  • Relief as drug ‘advertising’ plan ditched

    News | Health 29-09-2010

    Controversial plans to allow pharmaceutical companies to publish medicines information in newspapers have been scrapped by MEPs. The original proposal from the European Commission had been branded "advertising in disguise" by consumer groups, who welcomed the Parliament's U-turn.

Want to know what's going on in the EU Capitals daily? Subscribe now to our new 9am newsletter.